Klotho Gene Therapy for Healthy Adults
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the safety and effectiveness of a new gene therapy that uses a plasmid (a small DNA molecule) to deliver the Klotho gene in healthy adults. Researchers aim to determine if this gene therapy can improve cognition and overall health. Participants receive an injection and take part in health and memory tests before and after the treatment. Individuals who have not had cancer, gene therapy in the past year, or serious health problems, and are open to physical changes, might be suitable for this trial. As a Phase 1 trial, participants will be among the first to receive this new treatment, aiding researchers in understanding its effects on people.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research shows that the Klotho gene therapy, delivered using a nonviral plasmid, is currently being tested for safety in humans. Previous patients have generally tolerated this type of gene therapy well. In one study, a similar Klotho gene transfer did not cause any serious side effects. Another study using a different method with nanoparticles also demonstrated safe administration. While these results are encouraging, it is important to remember that this trial is in its early stages, focusing on safety and understanding potential effects.12345
Why do researchers think this study treatment might be promising?
Unlike the standard treatments, which often aim at managing symptoms or slowing progression, Klotho Gene Therapy directly enhances the expression of the Klotho gene, which is associated with longevity and improved cognitive function. This therapy is unique because it uses a plasmid to deliver the Klotho gene into the body, potentially offering a more direct and lasting impact on the aging process. Researchers are excited because this method could lead to improvements in cognitive health and overall well-being, potentially offering a new way to counteract age-related decline.
What evidence suggests that this gene therapy could be effective for cognitive and health benefits?
Research has shown that Klotho gene therapy might offer several health benefits. Animal studies have found that this therapy can improve memory, kidney function, and overall health, and may even extend lifespan. In one study, mice treated with Klotho gene therapy lived almost 20% longer and showed improvements in age-related changes in bones, muscles, and the brain. Although research in humans remains limited, these findings suggest that the therapy could potentially enhance brain function and increase healthy years of life in people. Participants in this trial will receive Klotho gene therapy to further investigate these potential benefits in humans.12367
Are You a Good Fit for This Trial?
This trial is for healthy adults who want to participate in a study testing the safety and effectiveness of a new gene therapy. Specific eligibility criteria are not provided, so generally, participants should be in good health without any major medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive subcutaneous injection of Klotho plasmid gene therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment, including cognitive and health assessments
What Are the Treatments Tested in This Trial?
Interventions
- Injectable Plasmid Klotho Gene Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Minicircle
Lead Sponsor